DrugPatentWatch Database Preview

Details for Patent: 8,241,243

« Back to Dashboard

Which drugs does patent 8,241,243 protect, and when does it expire?

Patent 8,241,243 protects SUMAVEL DOSEPRO and is included in one NDA.

This patent has nine patent family members in eight countries.

Summary for Patent: 8,241,243

Title:	Needleless injector drug capsule and a method for filling thereof
Abstract:	A method for filling needleless injector capsules with liquid drug, whereby dissolved gas within the drug is replaced by a less soluble gas in order to reduce the inclusion of gas bubbles, or to prevent the growth of bubbles during storage and thereby prevent breakage of the capsules.
Inventor(s):	William; Henry (Cambridge, GB), Andrew; Lewis (Cambridge, GB)
Assignee:	Zogenix, Inc. (Emeryville, CA)
Application Number:	10/496,357
Patent Claim Types: see list of patent claims	Formulation; Dosage form;

Drugs Protected by US Patent 8,241,243

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Endo Ventures Ltd	SUMAVEL DOSEPRO	sumatriptan succinate	INJECTABLE;SUBCUTANEOUS	022239-001	Jul 15, 2009		DISCN	Yes	No			Y

Foreign Priority and PCT Information for Patent: 8,241,243

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	0127942.1	Nov 21, 2001

PCT Information
PCT Filed	November 21, 2002	PCT Application Number:	PCT/GB02/05220
PCT Publication Date:	June 05, 2003	PCT Publication Number:	WO03/045479

Non-Orange Book US Patents Family Members for Patent 8,241,243

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No.	Title	Estimated Patent Expiration
8,491,524	Needleless injector drug capsule and a method for filling thereof
8,663,158	Needleless injector drug capsule and a method for filling thereof
8,118,771	Needleless injector drug capsule and a method for filling thereof
8,241,244	Needleless injector drug capsule and a method for filling thereof

International Patents Family Members for US Patent 8,241,243

Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	364417
Australia	2002343045
Canada	2468283
Germany	60220701